Patienternes egen rapportering af symptomer vha. ublindede vurderinger viste en klar tendens mod symptomforbedring med oral topotecan + BSC.
Patient self-reports of symptoms using an unblinded assessment showed a consistent trend for symptom benefit for oral topotecan + BSC.